Table 4.
Changes in CAP Parameters with CPAP Treatment
| CAP Parameters | Without CPAP | With CPAP | P |
|---|---|---|---|
| CAP/N3 (%) | 41.10 ± 3.01 | 32.98±1.58 | <0.05 |
| NCAP/N3 (%) | 46.08 ± 2.14 | 50.46 ± 0.88 | <0.05 |
| Phase A/N3 (%) | 12.18 (6.78–31.76) | 5.66 (2.74–23.54) | <0.01 |
| Phase B/N3 (%) | 25.63 ± 1.04 | 21.84 ± 0.81 | <0.05 |
| CAP A1/CAPs ratio (%) | 58.79 (44.59–73.19) | 71.39 (52.03–81.02) | <0.01 |
| CAP A2/CAPs ratio (%) | 15.12 (10.53–26.61) | 10.66 (5.16–21.98) | <0.05 |
| CAP A3/CAPs ratio (%) | 23.84 (12.58–34.31) | 17.16 (12.16–26.90) | <0.01 |
| Subtype A1 index | 21.23 (6.43–45.33) | 27.35 (10.57–70.40) | <0.05 |
| Subtype A2 index | 5.20 (2.61–16.00) | 2.83 (1.01–8.00) | <0.01 |
| Subtype A3 index | 6.34 (3.21–16.36) | 3.59 (1.91–11.20) | <0.01 |
| K complex index 1 | 7.42 (0.00–28.00) | 10.16 (1.36–58.81) | <0.05 |
| K complex index 2 | 0.00 (0.00–0.00) | 0.00 (0.00–0.00) | NS |
| K complex index 3 | 0.00 (0.00–0.00) | 0.00 (0.00–0.80) | NS |
Notes: Paired t-tests for data with normal distribution and Wilcoxon signed rank test for data with skew distribution. Values are presented as median (minimum-maximum).